Harm Reduction Clinical Trial
Official title:
Clinical Decision Support to Improve System Naloxone Co-prescribing
The objective of this study is to evaluate the impact of a clinical decision support (CDS) alert to facilitate the co-prescribing of naloxone, an opioid overdose reversal agent, with high-risk opioid prescriptions. Prescribing naloxone with opioids is a best practice described in the 2022 US Center for Disease Control and Prevention (CDC) guidelines on opioid prescribing. The CDS can improve quality of care delivered by improving compliance with the guideline defined best practices. The project will compare CDS alert facilitated co-prescribing of naloxone with high-risk opioid prescriptions vs usual care to evaluate the effectiveness of the CDS alert for improving naloxone prescribing. The patients are not assigned to an intervention and will be receiving any changes in care as part of their routine medical care, rather than a specific intervention that is distinct from their usual medical care. The researchers hypothesize that the CDS alert will be acceptable to providers while increasing naloxone co-prescribing which will reduce the number of opioid overdoses in subsequent 6 months.
Clinical decision support tools help clinicians make treatment decisions based on routinely collected data and offer a promising strategy to implement evidence-based practices for safe and effective pain management. This project will use clinical decision support tools embedded into electronic health records to help healthcare providers make treatment decisions that align with opioid prescribing guidelines from the Centers for Disease Control and Prevention (CDC). The project will also use information from prescription drug monitoring programs, insurance claims, and mortality data to evaluate patient outcomes. This research will evaluate how prescribing practices that align with CDC guidelines affect patient outcomes and whether clinical decision support tools provide an advantage over standard care practices for pain management. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05463341 -
Evaluating an Intervention to Prevent Overdoses in Rural and Urban Counties
|
N/A | |
Recruiting |
NCT02425657 -
Fast Track Module Based Colonoscopy Training Programme for Surgical Trainees at North Jutland Surgical Departments
|
||
Completed |
NCT04253158 -
Implementation of a Web-based Alcohol and Other Drug Prevention Intervention for Collegiate Student-athletes
|
N/A | |
Active, not recruiting |
NCT04700930 -
CBD Cigarettes Instead of Normal Cigarettes as Innovative Treatment for Schizophrenia
|
N/A | |
Recruiting |
NCT05994703 -
Assisting Smokers to Switch to an e-Cigarette by Accelerating Learning of Adaptive Habits Using D-cycloserine
|
Phase 2 | |
Completed |
NCT04210180 -
Combination of E-cigarettes and Varenicline for Tobacco Harm Reduction
|
Phase 2/Phase 3 | |
Recruiting |
NCT06115746 -
A Randomized Clinical Trial of a Novel Drug Education and Diversion Program (iDECIDE) for Middle and High School Students
|
N/A | |
Recruiting |
NCT05493475 -
Evaluation of a Novel Intervention to Prevent Polysubstance Overdoses Involving Illicit Stimulants
|
N/A | |
Terminated |
NCT03675503 -
Reducing Hospital Falls by Empowering Nurses to Provide Ambulatory Aids
|
N/A | |
Completed |
NCT01838473 -
In-vivo Extraction of Lead, Cadmium and Tobacco Specific Nitrosamines From Swedish 'Snus' in Regular Snus Users
|
Phase 1 | |
Completed |
NCT01369693 -
In-vivo Extraction of Pb, Cd and TSNA From Swedish Snus
|
Phase 1 | |
Completed |
NCT01249339 -
In-vivo Extraction of Pb, Cd andTSNA From Swedish Snus
|
Phase 1 | |
Completed |
NCT04250727 -
Switching to Potential Reduced Exposure Products in Adult Smokers
|
N/A | |
Completed |
NCT04650269 -
Implementation of Onsite, Rapid ART Initiation Among People Who Inject Drugs Living With HIV at Syringe Services Program
|
Phase 4 | |
Completed |
NCT04268173 -
Community-Based, Client-Centered Prevention Homes to Address the Rural Opioid Epidemic- Aim 3
|
Phase 3 | |
Not yet recruiting |
NCT04351958 -
An Augmented Reality Videogame for Alcohol Use Prevention and Harm Reduction in Teens
|
N/A | |
Active, not recruiting |
NCT05404815 -
Exposure to Plasticisers in the Neonatal Intensive Care Unit
|
||
Not yet recruiting |
NCT06429436 -
Vending Machine Naloxone Distribution for Your Community (VENDY)
|
Phase 4 | |
Not yet recruiting |
NCT06372899 -
Alternative Nicotine Delivery Systems as Potential Harm Reduction Tools for Persistent Cigarette Smokers
|
N/A | |
Recruiting |
NCT05516069 -
Our Healthbox - Evaluating Interactive Dispensing Systems for Low-Barrier Access to HIV Testing and Harm Reduction.
|
N/A |